Monitor for any future conversion to Schedule 13D, which would signal activist intent. For now, this is a routine passive ETF position with no immediate catalyst.
Price Chart
Executive Summary
AdvisorShares Trust disclosed a passive 5.78% stake in Neuphoria Therapeutics Inc. via Schedule 13G, holding 312,895 common shares as of September 30, 2026. The filing indicates no intent to influence control, consistent with a routine portfolio position by an ETF manager.
Key Financial Metrics
Key Facts
- AdvisorShares Trust filed a Schedule 13G disclosing beneficial ownership of 312,895 shares of Neuphoria Therapeutics Inc.
- The stake represents 5.78% of the company's common stock as of September 30, 2026.
- The filing certifies the shares were acquired and are held in the ordinary course of business, with no intent to change or influence control.
- The filing was made under Rule 13d-1(b), confirming passive investor status.
Financial Impact
5.78% passive stake valued at approximately $312,895 based on share count (no per-share price provided in filing).
Risk Factors
- AdvisorShares Trust could increase or decrease the position without further disclosure until crossing the next 5% threshold.
- The stake is relatively small in absolute terms, limiting potential influence.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0000929638-26-003845 |
| Document: 0000929638-26-003845-index.html | 0000929638-26-003845 |
| Document: 0000929638-26-003845.txt | 0000929638-26-003845 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 8-K | $3.44 | awaiting T+60 | — | $3.39 (−1.45%) |
Oct 5, 2026 22d ago | SC 13G | $3.45 | awaiting T+60 | — | $3.39 (−1.74%) |
Sep 18, 2026 5w ago | DEFA14A | $3.71 | awaiting T+60 | — | $3.39 (−8.63%) |
Sep 18, 2026 5w ago | DEFA14A | $3.71 | awaiting T+60 | — | $3.39 (−8.63%) |
Sep 18, 2026 5w ago | DEF 14A | $3.71 | awaiting T+60 | — | $3.39 (−8.63%) |
Jun 26, 2026 17w ago | Press Release | $4.40 $3.74 | ▼ −15.11% | ▼ −19.50% | $3.39 (−22.95%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers